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Infection with Mycobacterium tuberculosis, the causative agent of tuberculosis, is considered 
one of the biggest infectious disease killers worldwide. A significant amount of attention has 
been directed toward revealing genes involved in the virulence and pathogenesis of this air-
born pathogen. With the advances in technologies for transcriptional profiling, several groups, 
including ours, took advantage of DNA microarrays to identify transcriptional units differentially 
regulated by M. tuberculosis within a host. The main idea behind this approach is that pathogens 
tend to regulate their gene expression levels depending on the host microenvironment, and 
preferentially express those needed for survival. Identifying this class of genes will improve our 
understanding of pathogenesis. In our case, we identified an in vivo expressed genomic island 
that was preferentially active in murine lungs during early infection, as well as groups of genes 
active during chronic tuberculosis. Other studies have identified additional gene groups that 
are active during macrophage infection and even in human lungs. Despite all of these findings, 
one of the lingering questions remaining was whether in vivo expressed transcripts are relevant 
to the virulence, pathogenesis, and persistence of the organism. The work of our group and 
others addressed this question by examining the contribution of in vivo expressed genes using a 
strategy based on gene deletions followed by animal infections. Overall, the analysis of most of 
the in vivo expressed genes supported a role of these genes in M. tuberculosis pathogenesis. 
Further, these data suggest that in vivo transcriptional profiling is a valid approach to identify 
genes required for bacterial pathogenesis.
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able to reside and even replicate within the normally toxic phago-
somal compartment of human macrophages by using a variety of 
strategies, including the prevention of phagosome:lysosome fusion 
(Chua et al., 2004), prevention of phagosome acidification (Sturgill-
Koszycki et al., 1994), and detoxification of the stresses it encounters 
in this environment (Hingley-Wilson et al., 2003; Hestvik et al., 
2005; Warner and Mizrahi, 2007). One detriment to tuberculo-
sis research is the difficulty of working with the pathogenic M. 
tuberculosis bacteria. The severity of the disease combined with the 
extremely low infectious dose (1–10 bacteria) means that research 
must be conducted within specialized facilities. Further, the lengthy 
doubling time (approximately 1 day) makes work progress slowly 
while the unique, fatty-aid rich cell wall makes the extraction of 
well-preserved RNA difficult. As such, most of the expression stud-
ies conducted with M. tuberculosis have taken place in vitro and not 
within a living host. Until recently, in vivo analysis on a genome-
wide level was not even possible.
Fortunately, many in vitro models have been developed that 
attempt to replicate aspects of the in vivo environment using large-
scale analysis approaches, including low oxygen levels (Rustad et al., 
2008), low nutrients (Betts et al., 2002), and the addition of exog-
enous stresses (Stewart et al., 2002; Deb et al., 2009). While these 
models have been very useful in identifying and characterizing genes 
within M. tuberculosis, they are limited in their ability to identify 
survival strategies specific to the M. tuberculosis in vivo lifestyle. Our 
review will briefly discuss those in vitro models that improved our 
IntroductIon
While we are still uncovering the survival strategies used by 
M. tuberculosis within a host, it is clear that these strategies are 
very effective: approximately one-third of the world’s popula-
tion is infected with tuberculosis (Corbett et al., 2003). Infection 
progresses to active tuberculosis, characterized by coughing and 
weakness, in approximately 5–10% of cases. Without proper, long-
term treatment, tuberculosis can be fatal. Currently, the death rate 
from tuberculosis is approximately 1.7 million deaths per year, the 
highest for any single bacterial pathogen (Glaziou et al., 2009). 
Infected individuals who do not progress to active tuberculosis 
are said to develop latent tuberculosis, and represent a potential 
reservoir for future infection. Bacteria within latently infected indi-
viduals are often localized to granulomas, which are dense areas of 
both live and dead immune cells where the bacteria survive at a low 
but persistent level. Since the initial sequencing of M. tuberculosis 
in 1998 (Cole et al., 1998), many expression studies have been pub-
lished in an attempt to better understand the survival mechanisms 
of this deadly pathogen (Kendall et al., 2004; Waddell et al., 2008; 
Haller et al., 2010). In a post-genomic era, we now need to learn 
how to utilize these expression data to better understand the ever-
growing problem of tuberculosis.
Mycobacterium tuberculosis is an intracellular pathogen that 
infects via aerosolization from an infected host. After inhalation 
by a naïve host, the bacteria localize to the alveoli of the lungs, where 
they are phagocytosed by alveolar macrophages. M. tuberculosis is 
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quantization data, rather than relying on predicted open reading 
frames in a given genome. This allows for the identification of other 
types of RNA (e.g., sRNAs or non-coding RNAs). RNA-Seq may 
be able to provide particularly interesting data for host-pathogen 
infection models, as it is theoretically capable of profiling both 
the host and the pathogen simultaneously. Although RNA-Seq has 
yet to be used to study M. tuberculosis, other bacterial pathogens 
have been successfully profiled using this new technology (Cossart 
and Archambaud, 2009; Albrecht et al., 2010; Sharma et al., 2010). 
Applying RNA-Seq to tuberculosis is an area of active research in 
our laboratory and others. In an attempt to establish a protocol 
for RNA-Seq in our hands, we have used RNA-Seq to analyze the 
transcriptomes of M. tuberculosis cultures grown in vitro to mid-log 
phase. We found that using our designed GDPs (Talaat et al., 2000) 
yielded a better representation of the transcriptomes than using the 
standard random primers (see Table 1 for detailed results). Clearly, 
RNA-Seq provided a higher-resolution analysis of M. tuberculosis 
transcription that cannot be matched by our earlier analysis using 
DNA microarrays (Talaat et al., 2002).
tuberculosIs models of InfectIon
To gain insights into the molecular pathogenesis of M.  tuberculosis, 
many transcriptional profiling studies have been conducted within 
various models of tuberculosis infection. We will highlight the major 
tuberculosis models of infection suitable for transcriptional profiling 
techniques before delving into what we have learned from the gener-
ated M. tuberculosis transcriptomes. To begin, in vitro models have 
been developed that incorporate exposure of M.  tuberculosis growing 
in culture to conditions thought to be similar to those experienced 
within the host microenvironment. For example, studies have been 
conducted under exposure to acid, oxidative stress, and nutrient 
starvation (Betts et al., 2002; Fisher et al., 2002; Schnappinger et al., 
understanding of tuberculosis pathogenesis. However, this review 
focuses specifically on large-scale expression profiling experiments 
that have been conducted in vivo within host systems of tuberculo-
sis. In particular, we emphasize instances where in vivo expression 
profiling has led to the discovery of genes that have been confirmed 
experimentally to be required for full virulence and/or survival of 
M. tuberculosis. These discoveries suggest that in vivo expression 
profiling is a valid strategy to identify transcripts directly relevant 
to the development of tuberculosis.
major approaches for transcrIptIonal profIlIng of 
M. tuberculosis
Transcriptional profiling can be performed in several different 
ways. One of the simplest and most commonly used methods to 
determine transcript levels within bacteria such as M.  tuberculosis 
is RT-PCR. Because gene-specific primers are required for the 
amplification and quantification of transcripts, this technique is 
used for studies of specific genes that are of particular interest 
to the researcher. Because it measures transcript levels of only a 
small number of specific, pre-chosen genes, RT-PCR is not gener-
ally useful at identifying novel pathways or new targets for research. 
However, RT-PCR remains a popular and pragmatic technique for 
measuring gene expression, particularly during in vivo infection 
(Mariani et al., 2000; Timm et al., 2003; Shi et al., 2005; Srivastava 
et al., 2008; Kesavan et al., 2009). It is lower-cost than other profiling 
techniques, and it provides quantization levels that are generally 
considered to be more accurate than those provided by microar-
ray analyses. It requires less bacterial RNA than other techniques, 
making it desirable in situations where only small amounts of 
RNA can be recovered, as is frequently the case in M. tuberculosis 
in vivo infections. Because it is more accurate than whole-genome 
techniques, RT-PCR is used as a confirmatory step in almost all 
microarray studies.
On the other hand, whole-genome microarray analyses provide 
transcriptional profiling without bias toward previously known 
genes. In this way, microarrays are able to identify interesting tran-
scriptional changes in genes that may not have been previously 
characterized or studied, as well as large-scale trends occurring on 
a genome-wide level. Microarrays have frequently been used for the 
study of in vitro models of tuberculosis infection, but have been 
used less frequently to study in vivo models due to the difficulties 
in obtaining sufficient levels of mycobacterial RNA. Amplification 
techniques, although not yet widely utilized outside of human 
clinical samples, can alleviate this limitation in some situations 
(Waddell et al., 2008). Additionally, mycobacterial genome-directed 
primers (GDPs) have been developed to ensure that full-genome 
priming occurs in the presence of contaminating host transcripts 
(Talaat et al., 2000).
Recently, a novel sequencing-based approach for all RNA tran-
scripts, RNA-Seq, has emerged as an alternative to microarrays 
for whole-genome transcriptional profiling (Wang et al., 2009). 
Although RNA-Seq is significantly more expensive than microarray 
technology, and requires large amounts of high-quality extracted 
RNA, it also presents many advantages relative to older techniques. 
The quantization provided by RNA-Seq is significantly more accu-
rate than microarray analysis (Fu et al., 2009). Additionally, RNA-
Seq provides the actual transcript sequences simultaneously with 
Table 1 | Results from RNA-Seq of M. tuberculosis grown in vitro using 
random primers vs. genome-directed primers (GDPs).
 Random primers** GDPs**
Material submitted 1 μg RNA 1.5 μg cDNA
Total reads* 3,408,529 4,656,852
Total reads mapped 2,855,091 4,147,021
Reads mapped to  2,174,262 2,324,778 
rRNA or tRNA***
Unique coding sequence reads 672,632 1,807,890
Non-specific coding  8,197 14,353 
sequence reads
Reads not mapped 553,438 509,831
Most sequenced RNA (reads) rrl (1,442,762) rrl (1,388,167)
Most sequenced mRNA (reads) PPE60 (5,168) rv1398c (12,623)
Transcripts not detected 44 34
Sequencing was performed on Illumina Solexa Genome Analyzer II platform at 
the UW Biotechnology Center.
*Read length was 75 bp.
**R-value for reads using random primers vs. reads using GDPs was 0.913 
(R2 = 0.834).
***For both experiments, rRNA reduction was performed using MICROBExpress 
(Ambion) prior to amplification into cDNA with either random primers or GDPs.
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pathology during chronic infection, whereas the latent stage in 
humans is asymptomatic and characterized by low bacterial num-
bers (Flynn, 2006). Other less-common animal models include the 
use of guinea pigs, rabbits, and non-human primates for infec-
tions (Gupta and Katoch, 2005; Flynn, 2006). Financial restrictions 
and host-specific technical challenges mandates that large-scale 
transcriptional profiling has yet to be done within these models, 
although qRT-PCR has been used to profile select gene expression 
within infected rabbit lung tissue (Kesavan et al., 2009) as well as 
primate tissue (tbdb.org).
Finally, an additional option to obtain in vivo profiling data of 
pathogens is to isolate bacterial RNA directly from infected patients. 
In the case of M. tuberculosis, this requires access to sections of 
infected lung tissue, a limitation that has made profiling within 
human tissue rare. However, a few instances of transcriptional pro-
filing within human lungs have been reported (Timm et al., 2003; 
Rachman et al., 2006b). These studies can be considered the most 
accurate representation of genes expressed by M. tuberculosis during 
human infection. However, in addition to the difficulty in obtaining 
samples, other downsides to profiling within humans include the 
potential effect of chemotherapy treatment on bacterial transcrip-
tion, the potential introduction of artifacts during sample transport 
and storage, and the inability to reproduce experiments due to 
diverse genetic backgrounds. In the next sections, we will focus 
our attention on specific examples where large-scale analyses were 
useful in delineating novel aspects of tuberculosis pathogenesis.
genes expressed InsIde macrophages
the murIne macrophage model
A few whole-genome transcriptional profiles of M. tuberculosis 
growing within murine primary cell culture have been conducted 
using murine bone-marrow derived macrophages. Rachman 
et al. (2006a) used microarrays to profile the transcriptomes of 
M. tuberculosis within both active and resting macrophages rela-
tive to in vitro culture. Approximately 190 genes were identified 
as upregulated in response to the resting macrophage vs. liquid 
bacterial culture in vitro, or the activated macrophage vs. resting 
macrophage state. The upregulation of siderophore-encoding genes 
mbtJ and mbtI indicated that the bacteria were responding to iron 
limitation. Genes associated with amino acid synthesis and lipid 
metabolism were also upregulated, suggesting nutrient deprivation 
and the switch to lipids as a carbon source. Genes encoding cell wall 
components, stress response mechanisms, and regulatory proteins 
were also identified as induced within murine macrophages.
Similarly, Schnappinger et al. (2003) identified over 400 genes 
that were induced after phagocytosis by either resting or active 
murine macrophages relative to bacteria grown in culture. Despite 
the use of the same ex vivo model, only 27 genes were identified in 
both the Rachman and Schnappinger study (Figure 1A), possibly 
reflecting the differences in experimental conditions such as time 
points and bacterial load. Interestingly, despite the low number 
of overlap in genes identified in both studies, the functional cat-
egories identified were very similar. As with the Rachman study, 
the Schnappinger study found groups of genes associated with 
iron scavenging, the cell wall, and lipid metabolism. In addition, 
the Schnappinger study identified genes associated with anaero-
bic respiration and dormancy, such as narX and ndh, indicating 
2003). One of the most well-established in vitro models for M. 
tuberculosis is the Wayne model, which uses oxygen deprivation to 
mimic the conditions found in a tuberculosis granuloma (Wayne 
and Hayes, 1996; Wayne and Sohaskey, 2001). In another recently 
developed in vitro multiple stress model, M. tuberculosis bacilli are 
subjected to multiple stresses including low oxygen, high CO
2
, low 
nutrient availability, and acidic pH (Deb et al., 2009). These models 
have been useful in identifying and characterizing the genes within 
the M. tuberculosis genome.
A prime example of in vitro microarray studies includes those 
that identified the DosR regulon, a group of genes responsible for 
transitioning M. tuberculosis from an aerobic state to an anaerobic, 
persistent state (Park et al., 2003; Converse et al., 2009). However, 
although a knockout mutant of dosR caused attenuation within 
the mouse model, it was still able to establish a persistent infec-
tion (Converse et al., 2009). In addition to the inability of in vitro 
models to fully mimic the fluctuation and feedback found in an 
in vivo system, creating accurate in vitro models is also a difficult 
task because the conditions found in a mycobacterial phagosome 
are still not entirely known. Therefore, despite the utility of in vitro 
host models, particularly those that incorporate multiple stresses, 
they are unlikely to accurately represent the normal surroundings 
of intracellular pathogens such as M. tuberculosis. We are convinced 
that using in vivo models of infection will more closely represent the 
complex environment found in human lungs and provide a wealth 
of information related to M. tuberculosis pathogenesis.
Because M. tuberculosis is an intracellular pathogen, ex vivo 
macrophage infections can provide a model similar to its natu-
ral environment. Cell culture infections have been used to study 
host response to infection (Danelishvili et al., 2003; Xu et al., 2003; 
McGarvey et al., 2004), and several large-scale studies profiling 
the mycobacterial transcriptome have been done. Infected THP-1 
cells, which are cultured human monocytes, have been used to 
stimulate a host environment (Fontán et al., 2008). Additionally, 
primary cultures of murine macrophages as well as human mac-
rophages have been used for microarray analysis (Schnappinger 
et al., 2003; Cappelli et al., 2006; Rachman et al., 2006a; Tailleux 
et al., 2008). Although macrophages are more similar to the natural 
host environment than an in vitro system, the absence of interact-
ing immune cells such as T cell, natural killer cells, and dendritic 
cells, and the lack of a granulomatous structure, are disadvantages 
to cell culture systems.
While humans represent the only natural reservoir for 
M.  tuberculosis, many standard laboratory animals are capable 
of being infected with human strains via aerosolization, which 
most closely mimics natural infection. Mice represent the most 
commonly used animal model for tuberculosis, and the murine 
model provides a relatively tractable system in which to study M. 
tuberculosis pathogenesis. However, difficulty in isolating sufficient 
amounts of mycobacterial transcripts from host tissue mean that 
only a few large-scale transcriptional profiles within this model have 
been completed (Talaat et al., 2004, 2007). Additionally, the murine 
model is not able to completely replicate the biology of human 
tuberculosis. Although mice develop granulomas, they are not as 
defined and organized as the granulomas observed in humans, or 
even other animal models such as guinea pigs. Also, mice carry a 
high bacterial load and display progressively deteriorating lung 
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lated  intracellularly relative to M. tuberculosis grown in broth culture. 
Unlike the primary mouse macrophages, M. tuberculosis living within 
cultured human macrophages did not reveal upregulation of iron 
uptake genes. In fact, upregulation of bfrA, a gene associated with 
high levels of iron availability, occurred within this model. However, 
the THP-1 model identified other groups similar to those found in 
the murine macrophage studies, such as signs of lipid metabolism 
and cell envelope stress. This study also revealed the upregulation 
of many transcriptional regulators, including whiB3, ideR, mprA, 
and dosR. The THP-1 study had only 15 genes in common with 
the Rachman study, most of which encode uncharacterized hypo-
thetical proteins. On the other hand, it had a 71-gene overlap with 
the Schnappinger study, including many transcriptional regulators, 
membrane proteins, and lipid synthesis enzymes.
Additional microarray studies within human macrophages 
have used primary cultured macrophages isolated from healthy 
humans (Cappelli et al., 2006; Tailleux et al., 2008). Cappelli et al. 
(2006) discovered that genes associated with the cell wall, oxidative 
damage repair, and regulatory functions were upregulated, while 
iron-associated genes were not. The identification of the upregu-
lated sigma factor sigG in this study was unique to the primary 
culture human model, and SigG was confirmed to be required 
for full survival within macrophages (Lee et al., 2008). Tailleux 
et al. (2008) studied the transcriptional response of M. tuberculosis 
within human-derived macrophages as well as dendritic cells. The 
induction of genes associated with anaerobic respiration, includ-
ing narX, was observed, as well as the induction of genes associ-
ated with lipid metabolism. Interestingly, this study concluded that 
dendritic cells represent a more nutrient-limited environment for 
M. tuberculosis than macrophages, as evidenced by the increased 
upregulation of genes associated with amino acid synthesis and 
cholesterol metabolism.
overlap In macrophage-Induced genes
Comparing the transcriptional data from the two murine cell infec-
tions with the human THP-1 infection revealed only four genes that 
were identified as significantly upregulated in all three analyses, 
most likely due to differences in experimental setup (Schnappinger 
et al., 2003; Rachman et al., 2006a; Fontán et al., 2008). Two of 
these genes (rv1057, rv2012) are completely uncharacterized, and 
one is a putative methyltransferase (rv1405c) of unknown biologi-
cal function that was identified as necessary for infection within 
a mouse model (Sassetti and Rubin, 2003). The only functionally 
characterized gene identified in all three studies was isocitrate lyase 
(icl1), which is known to be involved in the utilization of fatty 
acids within the host (Höner Zu Bentrup et al., 1999). When icl1 
was knocked out and the mutant tested in a murine model, studies 
revealed attenuation in both persistence and virulence (McKinney 
et al., 2000; Muñoz-Elías and McKinney, 2005). Overall, the mac-
rophage studies have sketched the macrophage as a location where 
M. tuberculosis responds to oxidative stress, utilizes lipids as a car-
bon source, and modulates cell wall components. Other areas, such 
as iron availability, seem to provide different pictures depending on 
the cell culture model used. The high number of uncharacterized 
genes that are identified consistently among all macrophage studies 
emphasizes the need for continued basic research on characterizing 
the genome of M. tuberculosis.
that a switch to anaerobic respiration may occur in cell culture 
models, and particularly in macrophages that have been activated 
with IFN-γ. Curiously, the largest functional category within the 
overlap between the two studies was a high number of predicted 
transposases (6/27). Although the role for transposases within host 
infection is unknown, their upregulation is associated with DNA 
damage (Boshoff et al., 2003).
the human macrophage model
Microarray analysis performed by Fontán et al. (2008) 
examined macrophage infection using THP-1 cells, a human- derived 
cultured cell line. Approximately 380 genes were identified as upregu-
FiGuRe 1 | Meta-analysis of M. tuberculosis transcriptomes using 
variable models of infection. (A) Macrophage expression data following 
infection with M. tuberculosis reveals overlap of upregulated genes identified 
in three macrophage models of M. tuberculosis infection (Schnappinger et al., 
2003; Rachman et al., 2006a; Fontán et al., 2008). (B) Expression data in three 
models of tuberculosis infection, including ex vivo macrophage infection, 
mouse infection, and profiling of infected human lung tissue (Schnappinger 
et al., 2003; Talaat et al., 2004; Rachman et al., 2006a,b; Fontán et al., 2008).
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in liquid culture media. This region of the genome was termed the 
iVEGI, for in vivo expressed genomic island (Figure 2A). Since that 
publication, further characterization of all of the operons within 
the iVEGI has been an area of active research both in our labo-
ratory and others. We have come to understand more about the 
functions performed by the gene products encoded in the iVEGI, 
some of which were previously associated with in vivo survival, 
such as lipid synthesis, while others represented new insights into 
genes expressed durIng murIne InfectIon
In 2004, our group published an in vivo microarray analysis study 
of immune-competent and immune-deficient mice infected with 
M. tuberculosis (Talaat et al., 2004). Whole-genome expression lev-
els were measured weekly over the course of the first 4 weeks of 
infection. One of the major findings of this study was a region of 
32 consecutive genes that was highly expressed in the mouse lung 
tissue relative to its expression levels when grown outside the host, 
FiGuRe 2 | Analysis of key M. tuberculosis expressed genes in mice. 
(A) Schematic of the genetic organization of the in vivo expressed genomic island 
(iVEGI). Genes that have been targeted for deletion and tested for virulence within 
animal model(s) are bolded. (B) Murine survival curves after infection with the 
wild-type strain (H37Rv), or with targeted deletion strains created based on in vivo 
transcriptional profiling. Mouse groups were infected using aerosol infection 
(Glas-col inhalation system) using 100–300 CFU/animal (Abomoelak et al., 2009). 
The survival of infected mice was monitored over the course of a 1-year infection.
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The third operon of the iVEGI encodes a two-component 
regulatory system (MprAB; He and Zahrt, 2005), as well as a 
protease (PepD) (Mohamedmohaideen et al., 2008; White et al., 
2010) and an uncharacterized gene thought to be involved in 
molybdopterin synthesis (moaB2). The MprAB system consists 
of a response regulator (MprA) and a sensor kinase (MprB). 
This system has been shown to regulate many genes, including 
the genes encoding sigma factors SigB and SigE, in response 
to cellular stresses and particularly membrane stress (He et al., 
2006). An ∆mprAB deletion mutant failed to establish a per-
sistent infection in mice, suggesting that it could be required 
for the entrance into chronic tuberculosis (Zahrt and Deretic, 
2001). PepD is proposed to function as a protease and chap-
erone involved in mycobacterial stress response and is under 
the control of MprAB (Skeiky et al., 1999; Mohamedmohaideen 
et al., 2008; White et al., 2010). Similar to the ∆ctpV mutant, 
a ∆pepD mutant did not have a colonization defect within a 
mouse model, but animals infected with the mutant displayed 
less lung tissue damage relative to those infected with H37Rv, 
and mutant-infected mice lived longer than those infected with 
H37Rv (Mohamedmohaideen et al., 2008).
Operon 4 of the iVEGI encodes three genes: rv0986, rv0987, 
and rv0988, which together encode components of an ABC 
transporter (Braibant et al., 2000). Functional characterization 
of an ∆rv0986 knockout mutant revealed that this transporter 
is required for invasion of host cells as well as the blocking of 
phagosome–lysosome fusion within the host macrophage cell 
(Pethe et al., 2004; Rosas-Magallanes et al., 2006). Testing of a 
knockout mutant within this operon occurred within a murine 
model for central nervous system tuberculosis, with a knockout 
mutant of rv0986 less able to invade brain tissue (Be et al., 2008). 
Operon 4 is thus far the only operon shown to be horizontally 
transferred within the iVEGI. The operon as a whole is specific 
to the M. tuberculosis complex and has an unusually low GC con-
tent as well as distinct codon usage from the rest of the genome 
(Rosas-Magallanes et al., 2006). Overall, analysis conducted so 
far indicates the involvement of the iVEGI in M. tuberculosis 
pathogenesis and virulence.
In a second microarray study using the murine model that 
focused on the chronic stage of tuberculosis, mycobacterial RNA 
were successfully extracted from infected mouse lungs at 28, 45, 
and 60 days post-infection (Talaat et al., 2007). Surprisingly, 
these microarrays revealed that M. tuberculosis bacilli remain 
metabolically active during chronic tuberculosis, even though 
bacterial counts remain the same. Pathways for carbohydrate 
metabolism, lipid metabolism, and energy metabolism were sig-
nificantly upregulated. These analyses identified several clustered 
sets of genes, including a group of 12 in vivo expressed genes 
upregulated at all three time points relative to in vitro cultures. 
Included in this group was mprA of the iVEGI island as well as 
a previously uncharacterized gene, mosR, which was the most 
highly expressed gene of the cluster, at 200-fold upregulated. 
Further investigation of the role of MosR revealed that a ∆mosR 
strain is attenuated in a murine model of tuberculosis, and affects 
the expression of operons involved in mycobacterial survival at 
late stages of infection, likely through transcriptional regulation 
(Abomoelak et al., 2009).
environmental stress, such as copper toxicity and novel protease/
chaperone activity. Importantly, we have also shown that most of 
the operons within the iVEGI are required for full virulence within 
animal host models.
The first operon in the iVEGI, termed cso (copper sensitive 
operon), encodes four genes: csoR, rv0968, ctpV, and rv0970. The 
first gene, csoR, has been shown to encode a transcriptional regula-
tor that binds or releases DNA in response to the intracellular level 
of copper (Liu et al., 2007). At least one of the genes controlled 
by CsoR, ctpV, is directly involved in reducing the effects of cop-
per toxicity. CtpV is proposed to function as a copper exporter 
based on sequence analysis and experimental data (Ward et al., 
2010). Recent research suggests that copper toxicity may represent 
a source of host-mediated in vivo stress that successful pathogens 
must overcome through carefully regulated copper response mech-
anisms, such as those represented by CsoR and CtpV (Percival, 
1998; Wagner et al., 2005; Ward et al., 2010).
A knockout mutant of the entire cso operon was created, ∆cso, 
and was tested in a mouse model. Results showed an approxi-
mately 1.5-log reduction in the colonization levels of ∆cso relative 
to H37Rv, the virulent wild-type strain, at 38 weeks post-infection 
(Abomoelak et al., 2009). Additionally, a single-gene knockout of 
CtpV was created, ∆ctpV. This knockout mutant was tested in both 
a mouse model and a guinea pig model of infection (Ward et al., 
2010). The same phenotype was seen in both host models: although 
survival of ∆ctpV was similar to the wild-type strain H37Rv along 
the course of infection, damage to host tissue was lessened by the 
deletion of the ctpV gene, and mice infected with ∆ctpV survived 
longer relative to those infected with H37Rv (Figure 2B). This 
reduction in pathology and mortality shows that ctpV is required 
for full virulence of M. tuberculosis, despite not being required for 
survival within a host.
Operon 2 of the iVEGI encodes six genes predicted to be 
involved in lipid metabolism. The genes encode a putative enoyl-
CoA hydratase thought to be involved in the oxidation of fatty 
acids (echA7), two predicted acyl-coA dehydrogenases (fadE12, 
fadE13), two genes involved in the synthesis of mycolic acids (accA2, 
accD2), as well as one uncharacterized gene (rv0976c). Overall, the 
operon is likely involved in fatty acid metabolism and anabolism, 
processes key to M. tuberculosis pathogenesis, including forma-
tion of the unique cell wall as well the utilization of fatty acids as 
a carbon source. The genes involved in synthesizing and breaking 
down fatty acids are extremely prevalent within the M. tuberculosis 
genome, making it likely that some or all of the genes in Operon 2 
are redundant (Kinsella et al., 2003). A non-polar knockout of the 
first gene in Operon 2, echA7, was created in our laboratory using 
a specialized transduction system (Bardarov et al., 2002) and used 
to infect mice (Figure 2B). Despite its probable functional redun-
dancy, ∆echA7 showed attenuation in an aerosol mouse model of 
infection, with the ∆echA7 mutant colonizing with approximately 
one log fewer bacteria relative to H37Rv over the course of infec-
tion at both short-term (4 weeks) and long-term (up to 38 weeks) 
time points (data not shown). The ∆echA7 mutant also displayed 
extremely reduced virulence, with the infected mice surviving for 
the entire duration of the mouse survival experiment (1 year) com-
pared to the average time-to-death of mice infected with H37Rv 
(31 weeks) (Figure 2B).
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the model. For example, a comparison of genes upregulated in the 
human granuloma vs. genes upregulated in chronically infected 
mice revealed only four genes in common between the two data 
sets: PPE61, PPE55, rv0316, predicted to be involved in cholesterol 
utilization, and rv3706c, of unknown function. Between all genes 
upregulated in the murine and THP-1 macrophage models (860 
genes total) and the genes upregulated in the human granuloma 
(187 genes), only 42 genes overlapped (Table 2). This 42 gene over-
lap includes PPE61, PPE55, and rv3706 also found in the mouse 
model (Figure 1B; Table 2). Notably, PPE55 has also been identified 
as a potential vaccine target based on its antigenicity (Singh et al., 
2005; Zvi et al., 2008). However, as has been seen in other models, 
the largest category of genes identified in the human study was 
uncharacterized, hypothetical proteins.
concludIng remarks
In vivo studies have been very useful as a tool to better understand 
the host environment that M. tuberculosis experiences during human 
infection. Studies of macrophages, animal models, and even human 
lungs have all helped researchers make inferences about the host 
environment based on the reaction of M. tuberculosis to its surround-
ings. However, as tuberculosis continues to pose a looming threat to 
global health, it is important to mine through this expression data 
to infer clues not only about the host status but also about the fac-
tors enabling the virulence and pathogenesis of the bacteria. Studies 
conducted so far of strains containing mutations in genes identified 
through in vivo profiling suggest that this could be an effective way to 
identify gene products important to the bacteria. These genes could 
serve as interesting targets for applications such as vaccine creation 
and anti-mycobacterial drug targeting. Serving to complicate this 
process, the environment of M. tuberculosis is difficult to duplicate. 
Even within human host tissue itself, gene expression differs based 
on the biological variation seen not only from patient to patient, but 
even within different locations of the granuloma itself.
Despite these challenges, comparisons of the available data 
allows for the discovery of genes that are expressed highly in multi-
ple models and across different locations and time points, which can 
profIlIng of human InfectIon
A disadvantage of the in vivo models reviewed thus far is that, while 
host models can provide a closer insight into human pathogen-
esis than in vitro models, they are still unable to wholly replicate 
the natural, human environment of M. tuberculosis. A study of 
M. tuberculosis transcription within resected human lung tissue was 
conducted using qRT-PCR, with results compared to expression 
levels found in the murine model (Timm et al., 2003). Interestingly, 
this study found that genes associated with iron limitation were 
not as induced in human lung as they were in mouse lung, which 
together with the cell culture data presented earlier, suggests that 
metal availability within the phagosome could be species-specific. 
Expression levels of icl1, found to be highly expressed in the macro-
phage model and necessary for pathogenesis in the murine model, 
showed that icl1 levels vary depending on the lung specimen used, 
possibly due to differences in oxygen availability between different 
types of granulomatous tissue.
A second study used microarray analysis to profile the expression 
of M. tuberculosis in resected lung tissue removed from patients with 
severe tuberculosis, often caused by multiple drug resistant (MDR) 
strains (Rachman et al., 2006b). The profiling study revealed upregula-
tion of genes involved in the modification of the cell wall, including 
fatty and mycolic acids. Included in this group of cell wall-associated 
genes were many PE and PPE family genes, a family of surface proteins 
specific to mycobacteria whose function is not yet completely under-
stood (Bottai and Brosch, 2009). Genes for protein chaperones and 
detoxification activities were also identified, as was seen in the murine 
model, as well as genes associated with transposition and insertion 
elements, as had been identified in the macrophage models. Finally, 
genes involved in both aerobic and anaerobic respiration were seen, 
and the transcriptional profiles of these genes differed depending on 
the site of the tissue being studied (e.g., granuloma vs. distant lung 
tissue), supporting the idea that both aerobic and anaerobic models 
may be used to represent different sites of human infection.
Although the overall categories of genes identified in the human 
study were similar to those seen within mouse models of infection, 
the specific genes identified had little overlap with those found in 
Table 2 | The overlap in genes identified in multiple in vivo models, as represented in Figure 1B.
 intersection of cell culture  intersection of cell culture  
 and human granuloma data* and murine lung data**
DNA modification None rv1199c, rv2659c, rv3115, rv3023c
Energy and intermediate metabolism cyp141, fprB, gltA2, ppa, rocA, rv0083, rv2962c None
Lipid metabolism desA1, fadE30, fadD3, rv3229c nrp, papA2
Membrane-associated betP, lppZ, PE11, PE34, PPE55,  PPE55, PPE61, rv0188 
 PPE61, rv0797, rv2090, rv3636
Protein synthesis and repair asnB, clpP2, hsp, pyrG mshB
Regulatory proteins rv2642 mprA, rv0324
Uncharacterized rv0293c, rv0361, rv1738, rv1896c, rv1952, rv2005c,  rv0150c, rv1190, rv1291c, rv1518, rv1587c, 
 rv2160c, rv2262c, rv2557, rv2603c, rv3412,  rv1734c, rv1945, rv3706c, rv3845 
 rv3555c, rv3626c, rv3706c, rv3776, rv3860, rv3861
*Genes were identified as upregulated within cell culture experiments (Schnappinger et al., 2003; Rachman et al., 2006a; Fontán et al., 2008) and human lung 
granulomas (Rachman et al., 2006b).
**Genes were identified as upregulated within cell culture experiments (Schnappinger et al., 2003; Rachman et al., 2006a; Fontán et al., 2008) and murine lung 
tissue (Talaat et al., 2004).
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